Basic Information


GTO ID GTC2922
Trial ID NCT05227378
Disease Stomach Cancer
TherapymRNA vaccine
Treatment neoantigen tumor Vaccine
Co-treatment PD-1/L1
PhaseNot Applicable
Recruitment statusNot Recruiting
TitleA Singlre Arm, Open Label Study on the Safety and Efficacy of Neoantigen Tumor Vaccine in Advanced Gastric Cancer
Year2022
CountryChina
Company sponsorShen Lin
Other ID(s)XKY-1004

Clinical Result

Cohort1: neoantigen tumor vaccine_dose escalation phase_dose level 1
Administration route None
Dosage neoantigen tumor vaccine, 100 μg
Pts 6
Age Adult, Older_Adult
Cohort2: neoantigen tumor vaccine_dose escalation phase_dose level 2
Administration route None
Dosage neoantigen tumor vaccine, 200 μg
Pts 6
Age Adult, Older_Adult
Cohort3: neoantigen tumor vaccine_dose escalation phase_dose level 3
Administration route None
Dosage neoantigen tumor vaccine, 400 μg
Pts 6
Age Adult, Older_Adult
Cohort4: neoantigen tumor vaccine_dose expansion phase
Administration route None
Pts 18
Age Adult, Older_Adult

Relationship Graph

Overview of Knowledge Graph